• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于89例颞骨癌手术的多中心经验。

Multicenter experiences in temporal bone cancer surgery based on 89 cases.

作者信息

Wierzbicka Małgorzata, Niemczyk Kazimierz, Bruzgielewicz Antoni, Durko Marcin, Klatka Janusz, Kopeć Tomasz, Osuch-Wójcikiewicz Ewa, Pietruszewska Wioletta, Szymański Marcin, Szyfter Witold

机构信息

ENT Department, Medical University, Poznań, Poland.

ENT Department, Medical University, Warsaw, Poland.

出版信息

PLoS One. 2017 Feb 22;12(2):e0169399. doi: 10.1371/journal.pone.0169399. eCollection 2017.

DOI:10.1371/journal.pone.0169399
PMID:28225795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5321293/
Abstract

OBJECTIVE

To present outcomes of extensive surgery: lateral, subtotal, total petrosectomies in patients with temporal bone invasion resulting from specific primary cancers.

STUDY DESIGN

Retrospective case review.

SETTING

Four tertiary referral centers.

MATERIAL

89 patients with cancer of the temporal bone treated between January 2006 and December 2010.

INTERVENTION

Multidisciplinary team approach including surgical resection, reconstruction, and postoperative radiotherapy.

MAIN OUTCOME MEASURE

Disease-specific survival, overall survival.

RESULTS

In 27.0% of the patients, relapse was reported, with an average of 6.3 months after surgery; 31 patients (34.8%) died during the follow-up. The average mortality was 22.1 months. Fifty-four patients (58.7%) stayed alive during the time of observation. The average survival time was 42.0 months. The median time of survival with relapse was 12 months (range: 1-51 months). The three-year disease-free rate was 38.0% and the overall survival rate was 58.7%.

CONCLUSIONS

Petrosectomy is an effective treatment for malignant temporal bone invasion. The probability of a good outcome was statistically decreased with a high T grade, positive margins, and salvage surgery. Younger age is connected with better prognosis. One of the major tasks remains to improve detection and to shorten the time to diagnosis, keeping in mind that symptoms are insidious and in younger people, the time before diagnosis was longer.

摘要

目的

介绍针对因特定原发性癌症导致颞骨侵犯患者进行广泛手术(外侧、次全、全岩骨切除术)的结果。

研究设计

回顾性病例分析。

研究地点

四个三级转诊中心。

资料

2006年1月至2010年12月期间接受治疗的89例颞骨癌症患者。

干预措施

多学科团队治疗方法,包括手术切除、重建及术后放疗。

主要观察指标

疾病特异性生存率、总生存率。

结果

27.0%的患者出现复发,平均复发时间为术后6.3个月;31例患者(34.8%)在随访期间死亡。平均死亡时间为22.1个月。54例患者(58.7%)在观察期内存活。平均生存时间为42.0个月。复发后生存的中位时间为12个月(范围:1 - 51个月)。三年无病生存率为38.0%,总生存率为58.7%。

结论

岩骨切除术是治疗恶性颞骨侵犯的有效方法。高T分级、切缘阳性及挽救性手术会使良好预后的概率在统计学上降低。年轻患者预后较好。主要任务之一仍是改善检测并缩短诊断时间,要记住症状隐匿,且在年轻患者中,诊断前的时间更长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e34/5321293/e369b945fee0/pone.0169399.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e34/5321293/56495050a970/pone.0169399.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e34/5321293/1fcf8ae47cae/pone.0169399.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e34/5321293/e369b945fee0/pone.0169399.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e34/5321293/56495050a970/pone.0169399.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e34/5321293/1fcf8ae47cae/pone.0169399.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e34/5321293/e369b945fee0/pone.0169399.g003.jpg

相似文献

1
Multicenter experiences in temporal bone cancer surgery based on 89 cases.基于89例颞骨癌手术的多中心经验。
PLoS One. 2017 Feb 22;12(2):e0169399. doi: 10.1371/journal.pone.0169399. eCollection 2017.
2
Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone.手术治疗 72 例颞骨鳞状细胞癌的生存结果。
Otol Neurotol. 2011 Jun;32(4):665-9. doi: 10.1097/MAO.0b013e318210b90f.
3
Squamous cell carcinoma of the temporal bone: clinical outcomes from radical surgery and postoperative radiotherapy.颞骨鳞状细胞癌:根治性手术及术后放疗的临床疗效
Otol Neurotol. 2014 Mar;35(3):501-8. doi: 10.1097/MAO.0000000000000265.
4
Survival impact of local extension sites in surgically treated patients with temporal bone squamous cell carcinoma.颞骨鳞状细胞癌手术治疗患者局部扩展部位的生存影响
Int J Clin Oncol. 2017 Jun;22(3):431-437. doi: 10.1007/s10147-016-1076-8. Epub 2017 Jan 2.
5
Evaluation of results of temporal bone resection.颞骨切除术结果的评估。
Acta Neurochir (Wien). 1991;110(3-4):110-5. doi: 10.1007/BF01400676.
6
Squamous cell carcinoma involving the temporal bone: lateral temporal bone resection as primary intervention.涉及颞骨的鳞状细胞癌:作为主要干预手段的外侧颞骨切除术。
Otol Neurotol. 2013 Jan;34(1):141-50. doi: 10.1097/MAO.0b013e318278bf38.
7
[The outcome of treatments for carcinoma of the external auditory canal].[外耳道癌的治疗结果]
Rev Laryngol Otol Rhinol (Bord). 2005;126(3):165-70.
8
Squamous cell carcinoma of the temporal bone: results and management.颞骨鳞状细胞癌:结果与治疗
Otol Neurotol. 2008 Jun;29(4):549-52. doi: 10.1097/MAO.0b013e31816c7c71.
9
Squamous cell carcinoma of the temporal bone.颞骨鳞状细胞癌
J Laryngol Otol. 2008 Nov;122(11):1156-61. doi: 10.1017/S0022215107001338. Epub 2008 Jan 7.
10
Efficacy of petrosectomy in malignant invasion of the temporal bone.颞骨岩部切除术治疗颞骨恶性侵犯的疗效
Br J Oral Maxillofac Surg. 2016 Sep;54(7):778-83. doi: 10.1016/j.bjoms.2016.05.002. Epub 2016 May 27.

引用本文的文献

1
The Naples Prognostic Score Exerts a Significant Impact on the Prognosis of Patients Diagnosed with External Auditory Canal Carcinoma After Surgery.那不勒斯预后评分对手术治疗的外耳道癌患者的预后有显著影响。
Cancer Manag Res. 2025 May 25;17:985-996. doi: 10.2147/CMAR.S527496. eCollection 2025.
2
The international expert consensus on management of external auditory canal carcinoma.外耳道癌管理的国际专家共识
Eur Arch Otorhinolaryngol. 2025 Apr;282(4):1677-1691. doi: 10.1007/s00405-024-09033-w. Epub 2024 Oct 28.
3
Algorithms of follow-up in patients with head and neck cancer in relation to primary location and advancement. Consensus of Polish ENT Society Board and Head Neck Experts.

本文引用的文献

1
Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.碳离子放疗用于局部晚期外耳道和中耳鳞状细胞癌
Head Neck. 2016 Apr;38(4):512-6. doi: 10.1002/hed.23905. Epub 2015 May 26.
2
Arterial chemoradiotherapy for carcinomas of the external auditory canal and middle ear.外耳道和中耳癌的动脉化疗放疗
Laryngoscope. 2015 Mar;125(3):685-9. doi: 10.1002/lary.24908. Epub 2014 Aug 26.
3
Prognostic models to predict overall and cause-specific survival for patients with middle ear cancer: a population-based analysis.
与原发部位和进展相关的头颈癌患者随访算法。波兰耳鼻喉科学会理事会和头颈专家共识。
Front Oncol. 2023 Dec 12;13:1298541. doi: 10.3389/fonc.2023.1298541. eCollection 2023.
4
Necrotizing Otitis Concealing Carcinomas of the External Auditory Canal.隐匿性外耳道坏死性中耳炎伴外耳道癌
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):4306-4313. doi: 10.1007/s12070-021-02972-4. Epub 2021 Nov 13.
5
Treatment, Survival, and Demographics in Temporal Bone Malignancies: A Pooled Data Analysis.颞骨恶性肿瘤的治疗、生存情况及人口统计学特征:一项汇总数据分析
Cureus. 2022 Nov 28;14(11):e31973. doi: 10.7759/cureus.31973. eCollection 2022 Nov.
6
Treatment Strategies for Malignancies of the External Auditory Canal.外耳道恶性肿瘤的治疗策略
Curr Treat Options Oncol. 2022 Jan;23(1):43-53. doi: 10.1007/s11864-021-00931-3. Epub 2022 Feb 15.
7
Management of Temporal Bone Malignancy in Ireland.爱尔兰颞骨恶性肿瘤的管理
J Neurol Surg B Skull Base. 2020 Dec;81(6):680-685. doi: 10.1055/s-0039-1696723. Epub 2019 Aug 29.
8
Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.评价改良的匹兹堡分类法预测外耳道鳞癌无病生存结局的能力。
Head Neck. 2020 Dec;42(12):3609-3622. doi: 10.1002/hed.26424. Epub 2020 Aug 13.
9
Anterolateral thigh free flap in reconstruction of lateral skull base defects after oncological resection.股前外侧游离皮瓣在颅底侧部肿瘤切除后重建中的应用。
Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3487-3494. doi: 10.1007/s00405-019-05627-x. Epub 2019 Sep 12.
预测中耳癌患者总生存率和特定病因生存率的预后模型:一项基于人群的分析。
BMC Cancer. 2014 Aug 1;14:554. doi: 10.1186/1471-2407-14-554.
4
To analyze the impact of intracavitary brachytherapy as boost radiation after external beam radiotherapy in carcinoma of the external auditory canal and middle ear: a retrospective analysis.分析腔内近距离放射治疗作为外耳道和中耳癌外照射放疗后补充放疗的影响:一项回顾性分析。
J Cancer Res Ther. 2014 Apr-Jun;10(2):342-6. doi: 10.4103/0973-1482.136624.
5
Squamous cell carcinoma of the temporal bone: clinical outcomes from radical surgery and postoperative radiotherapy.颞骨鳞状细胞癌:根治性手术及术后放疗的临床疗效
Otol Neurotol. 2014 Mar;35(3):501-8. doi: 10.1097/MAO.0000000000000265.
6
Neurotologic skull base access for primary tumors of the temporomandibular joint.神经耳科学颅底入路治疗颞下颌关节原发性肿瘤。
Otol Neurotol. 2013 Dec;34(9):1748-51. doi: 10.1097/MAO.0b013e3182a1ac1c.
7
Treatment and outcome of middle ear cancer.中耳癌的治疗与预后
Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2675-80. doi: 10.1007/s00405-013-2728-1.
8
Comparison of TNM-based stage grouping versus UICC/AJCC stage grouping (7th edition) in malignant parotid gland tumors.TNM 分期系统与 UICC/AJCC 分期系统(第 7 版)在腮腺恶性肿瘤中的比较。
Oral Oncol. 2013 Sep;49(9):903-910. doi: 10.1016/j.oraloncology.2013.06.009. Epub 2013 Jul 10.
9
Squamous cell carcinoma of the temporal bone: outcomes of radical surgery and postoperative radiotherapy.颞骨鳞状细胞癌:根治性手术和术后放疗的结果。
Laryngoscope. 2013 Oct;123(10):2442-8. doi: 10.1002/lary.24063. Epub 2013 Apr 1.
10
Temporal bone malignancies.颞骨恶性肿瘤。
Neurosurg Clin N Am. 2013 Jan;24(1):97-110. doi: 10.1016/j.nec.2012.08.009.